These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 27462980)

  • 1. Targeting MT1-MMP as an ImmunoPET-Based Strategy for Imaging Gliomas.
    de Lucas AG; Schuhmacher AJ; Oteo M; Romero E; Cámara JA; de Martino A; Arroyo AG; Morcillo MÁ; Squatrito M; Martinez-Torrecuadrada JL; Mulero F
    PLoS One; 2016; 11(7):e0158634. PubMed ID: 27462980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MT1-MMP as a PET Imaging Biomarker for Pancreas Cancer Management.
    Morcillo MÁ; García de Lucas Á; Oteo M; Romero E; Magro N; Ibáñez M; Martínez A; Garaulet G; Arroyo AG; López-Casas PP; Hidalgo M; Mulero F; Martínez-Torrecuadrada J
    Contrast Media Mol Imaging; 2018; 2018():8382148. PubMed ID: 30224904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Target engagement of an anti-MT1-MMP antibody for triple-negative breast cancer PET imaging and beta therapy.
    Magro N; Oteo M; Romero E; Ibáñez-Moragues M; Lujan VM; Martínez L; Vela O; López-Melero ME; Arroyo AG; Garaulet G; Martínez-Torrecuadrada JL; Mulero F; Morcillo MA
    Nucl Med Biol; 2024; 136-137():108930. PubMed ID: 38833768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ImmunoPET Imaging of CD146 Expression in Malignant Brain Tumors.
    Hernandez R; Sun H; England CG; Valdovinos HF; Barnhart TE; Yang Y; Cai W
    Mol Pharm; 2016 Jul; 13(7):2563-70. PubMed ID: 27280694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of PEGylated peptide probes conjugated with (18)F-labeled BODIPY for PET/optical imaging of MT1-MMP activity.
    Kondo N; Temma T; Deguchi J; Sano K; Ono M; Saji H
    J Control Release; 2015 Dec; 220(Pt A):476-483. PubMed ID: 26578437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of membrane type-1 matrix metalloproteinase-specific activatable fluorescent probe for malignant tumor detection.
    Shimizu Y; Temma T; Sano K; Ono M; Saji H
    Cancer Sci; 2011 Oct; 102(10):1897-903. PubMed ID: 21718387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioimmunodetection of membrane type-1 matrix metalloproteinase relevant to tumor malignancy with a pre-targeting method.
    Sano K; Temma T; Kuge Y; Kudo T; Kamihashi J; Zhao S; Saji H
    Biol Pharm Bull; 2010; 33(9):1589-95. PubMed ID: 20823579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical ImmunoPET Imaging of Glioblastoma-Infiltrating Myeloid Cells Using Zirconium-89 Labeled Anti-CD11b Antibody.
    Nigam S; McCarl L; Kumar R; Edinger RS; Kurland BF; Anderson CJ; Panigrahy A; Kohanbash G; Edwards WB
    Mol Imaging Biol; 2020 Jun; 22(3):685-694. PubMed ID: 31529407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting CD146 with a 64Cu-labeled antibody enables in vivo immunoPET imaging of high-grade gliomas.
    Yang Y; Hernandez R; Rao J; Yin L; Qu Y; Wu J; England CG; Graves SA; Lewis CM; Wang P; Meyerand ME; Nickles RJ; Bian XW; Cai W
    Proc Natl Acad Sci U S A; 2015 Nov; 112(47):E6525-34. PubMed ID: 26553993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immuno-PET Imaging of CD30-Positive Lymphoma Using 89Zr-Desferrioxamine-Labeled CD30-Specific AC-10 Antibody.
    Rylova SN; Del Pozzo L; Klingeberg C; Tönnesmann R; Illert AL; Meyer PT; Maecke HR; Holland JP
    J Nucl Med; 2016 Jan; 57(1):96-102. PubMed ID: 26514172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 89Zr-DFO-J591 for immunoPET of prostate-specific membrane antigen expression in vivo.
    Holland JP; Divilov V; Bander NH; Smith-Jones PM; Larson SM; Lewis JS
    J Nucl Med; 2010 Aug; 51(8):1293-300. PubMed ID: 20660376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioiodinated Peptidic Imaging Probes for in Vivo Detection of Membrane Type-1 Matrix Metalloproteinase in Cancers.
    Kondo N; Temma T; Shimizu Y; Ono M; Saji H
    Biol Pharm Bull; 2015; 38(9):1375-82. PubMed ID: 26328493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Miniaturized antibodies for imaging membrane type-1 matrix metalloproteinase in cancers.
    Kondo N; Temma T; Shimizu Y; Watanabe H; Higano K; Takagi Y; Ono M; Saji H
    Cancer Sci; 2013 Apr; 104(4):495-501. PubMed ID: 23305265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a radiolabeled probe for detecting membrane type-1 matrix metalloproteinase on malignant tumors.
    Temma T; Sano K; Kuge Y; Kamihashi J; Takai N; Ogawa Y; Saji H
    Biol Pharm Bull; 2009 Jul; 32(7):1272-7. PubMed ID: 19571397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetraarsenic oxide-induced inhibition of malignant glioma cell invasion in vitro via a decrease in matrix metalloproteinase secretion and protein kinase B phosphorylation.
    Gwak HS; Park MJ; Park IC; Woo SH; Jin HO; Rhee CH; Jung HW
    J Neurosurg; 2014 Dec; 121(6):1483-91. PubMed ID: 25303017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD146-targeted immunoPET and NIRF Imaging of Hepatocellular Carcinoma with a Dual-Labeled Monoclonal Antibody.
    Hernandez R; Sun H; England CG; Valdovinos HF; Ehlerding EB; Barnhart TE; Yang Y; Cai W
    Theranostics; 2016; 6(11):1918-33. PubMed ID: 27570560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and
    Pringle TA; Chan CD; Luli S; Blair HJ; Rankin KS; Knight JC
    Bioconjug Chem; 2022 Aug; 33(8):1564-1573. PubMed ID: 35867034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative PET imaging and fluorescence-guided surgery of human glioblastoma using dual-labeled antibody targeting ET
    Hautiere M; Vivier D; Dorval P; Pineau D; Kereselidze D; Denis C; Herbet A; Costa N; Bernhard C; Goncalves V; Selingue E; Larrat B; Dancer PA; Hugnot JP; Boquet D; Truillet C; Denat F
    Theranostics; 2024; 14(16):6268-6280. PubMed ID: 39431005
    [No Abstract]   [Full Text] [Related]  

  • 19. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
    Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
    J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical 89Zr Immuno-PET of High-Grade Serous Ovarian Cancer and Lymph Node Metastasis.
    Sharma SK; Sevak KK; Monette S; Carlin SD; Knight JC; Wuest FR; Sala E; Zeglis BM; Lewis JS
    J Nucl Med; 2016 May; 57(5):771-6. PubMed ID: 26837339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.